The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cancer risk assessment in patients with persistent pulmonary nodules and its correlation with cancer-free survival.
 
Hui Li
No Relationships to Disclose
 
Kang Qin
No Relationships to Disclose
 
Zheng Zhang
No Relationships to Disclose
 
Lingzhi Hong
No Relationships to Disclose
 
Carol C. Wu
No Relationships to Disclose
 
Myrna Cobos Barco Godoy
Consulting or Advisory Role - Siemens Healthineers
Research Funding - Siemens Healthineers (Inst); Siemens Healthineers (Inst)
 
Mara Antonoff
Consulting or Advisory Role - AstraZeneca; AstraZeneca
 
Edwin J. Ostrin
No Relationships to Disclose
 
Iakovos Toumazis
No Relationships to Disclose
 
Don Lynn Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar
Consulting or Advisory Role - 4D Pharma; AstraZeneca; Lilly; Menarini; Onconova Therapeutics; Sanofi
Research Funding - Astellas Pharma; AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen; NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
John Heymach
Consulting or Advisory Role - AstraZeneca; BerGenBio; Boehringer Ingelheim; Bristol-Myers Squibb; DAVA Pharmaceuticals; EMD Serono; Genentech/Roche; GlaxoSmithKline; Hengrui Pharmaceutical; Janssen; Jazz Pharmaceuticals; Jazz Pharmaceuticals; Lilly (Inst); Mirati Therapeutics; Nexus Health Systems; Pneuma Respiratory; Regeneron; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Speakers' Bureau - DAVA Pharmaceuticals; IDEOlogy Health; MJH Life Sciences
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Spectrum Pharmaceuticals; Takeda (Inst)
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations
 
J. Jack Lee
Honoraria - AstraZeneca; AstraZeneca
 
Jia Wu
No Relationships to Disclose
 
Jianjun Zhang
Honoraria - CancerNet; Geneplus; Geneplus; Hengrui Medicine; Innovent Biologics; Innovent Biologics; innovent biologics; Origimed; Roche; Sino-USA Biomedical Platform; Suzhou Medical Association; Varian Medical Systems; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Hunan Cancer Hospital; Johnson & Johnson/Janssen; Novartis
Research Funding - Merck; Novartis
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital